Editöre Mektup
BibTex RIS Kaynak Göster

WHO treatment guidelines against leprosy: a focus on pharmacovigilance.

Yıl 2019, Cilt: 44 Sayı: 2, 701 - 702, 30.06.2019

Pugazhenthan Thangaraju , Sajitha Venkatesan

https://doi.org/10.17826/cumj.511810
https://izlik.org/JA36LE86PF

Öz

A focus on Pharmacovigilance


Anahtar Kelimeler

leprosy guideline pharmacovigilance

Kaynakça

  • 1. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy. http://nlep.nic.in/pdf/WHO%20Guidelines%20for%20leprosy.pdf Retrieved on 10/01/2019.
  • 2. Pharmacovigilance. https: //www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/. Accessed on 11/01/2019.
  • 3. Thangaraju P, Venkatesan S, Tamilselvan T, Sivashanmugam E, Showkath Ali M K. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring among medical professionals attending Central Leprosy Institute. Mustansiriya Med J 2018;17:63-8

DSÖ lepra tedavi kılavuzu: farmakovijilansa odaklanma

Yıl 2019, Cilt: 44 Sayı: 2, 701 - 702, 30.06.2019

Pugazhenthan Thangaraju , Sajitha Venkatesan

https://doi.org/10.17826/cumj.511810
https://izlik.org/JA36LE86PF

Öz

-

Anahtar Kelimeler

Leprosy Guideline pharmaccovigilance

Kaynakça

  • 1. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy. http://nlep.nic.in/pdf/WHO%20Guidelines%20for%20leprosy.pdf Retrieved on 10/01/2019.
  • 2. Pharmacovigilance. https: //www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/. Accessed on 11/01/2019.
  • 3. Thangaraju P, Venkatesan S, Tamilselvan T, Sivashanmugam E, Showkath Ali M K. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring among medical professionals attending Central Leprosy Institute. Mustansiriya Med J 2018;17:63-8
Toplam 3 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Editöre Mektup
Yazarlar

Pugazhenthan Thangaraju 0000-0002-4090-2004

Sajitha Venkatesan Bu kişi benim 0000-0001-9147-2553

Kabul Tarihi 12 Ocak 2019
Yayımlanma Tarihi 30 Haziran 2019
DOI https://doi.org/10.17826/cumj.511810
IZ https://izlik.org/JA36LE86PF
Yayımlandığı Sayı Yıl 2019 Cilt: 44 Sayı: 2

Kaynak Göster

MLA Thangaraju, Pugazhenthan, ve Sajitha Venkatesan. “WHO treatment guidelines against leprosy: a focus on pharmacovigilance”. Cukurova Medical Journal, c. 44, sy 2, Haziran 2019, ss. 701-2, doi:10.17826/cumj.511810.

Cited By

ESBL Producing Escherichia coli in Faecal Sludge Treatment Plants: An Invisible Threat to Public Health in Rohingya Camps, Cox's Bazar, Bangladesh
Frontiers in Public Health
https://doi.org/10.3389/fpubh.2021.783019
Design and Cross-Cultural Invariance of the COVID-19 Vaccine Conspiracy Beliefs Scale (COVID-VCBS) in 13 Latin American Countries
Frontiers in Public Health
https://doi.org/10.3389/fpubh.2022.908720
Impact of COVID-19 on HIV services and anticipated benefits of vaccination in restoring HIV services in Ethiopia: A qualitative assessment
Frontiers in Public Health
https://doi.org/10.3389/fpubh.2022.1033351
The Effect of Interventions on the Prevention of Parental Vaccine Refusal and Hesitancy: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Güncel Pediatri
https://doi.org/10.4274/jcp.2022.13334
Creative Commons Lisansı